A 22-year-old tennis champion just backed a controversial new gene test in women’s sports while warning it is already being used to turn people against each other.
Story Snapshot
- Coco Gauff says she supports both the trans community and “fairness in women’s sports” under the new gene-testing rule.
- The Women’s Tennis Association will require a one-time SRY gene test to define who can play on the women’s tour.
- Gauff warns the policy debate is fueling “animosity toward the trans community” and being weaponized by people who “don’t really care.”
- The fight over this rule taps into a deeper distrust of sports and political elites who rewrite the rules without real public input.
Coco Gauff’s ‘two things can be true’ message
After her opening win at the Canadian Open in Toronto, Coco Gauff was asked about the Women’s Tennis Association’s new genetic-testing rule for the women’s tour. Gauff said she understands “the reasoning behind it” and that she “kind of agree[s] with trying to protect the fairness in women’s sports.” At the same time, she said she “definitely support[s] the trans community” and does not like how the debate is being used to create hate.
Gauff explained that this is a “very nuanced” topic where “two things can be true at once.” She backed the idea that women’s tennis must account for biological differences but drew a clear line against using that concern as a weapon. She said some people “don’t really care” about tennis or fairness and are “just want[ing] to use this as a reason to attack the trans community.” That, she stressed, is something she will not support.
What the new WTA gene-testing rule actually does
The Women’s Tennis Association recently changed its eligibility rules to require a one-time genetic sex test for every player on the women’s tour. The test looks for the SRY gene, a small piece of DNA usually found on the Y chromosome that starts male sexual development before birth. Under the policy, anyone who has the SRY gene is classified as a biological male, and anyone without it is classified as a biological female, no matter their legal sex or gender identity.
The Women’s Tennis Association says the goal is to “preserve the integrity of women’s professional tennis and maintain fair competition conditions for all players.” The test can be done with a cheek swab, blood sample, or saliva and is only required once during a player’s career. The rule also recognizes rare medical conditions where typical testosterone effects do not apply and makes room for those cases. Officials insist they do not intend to disrespect anyone’s gender identity or dignity.
Why this strikes a nerve on both left and right
This rule lands in a country already divided over who writes the rules and who pays the price. Conservatives who worry that biological women are losing chances in sports may see the Women’s Tennis Association policy as long overdue. For years, they have felt that powerful sports bodies and global committees cared more about politics than about protecting a level playing field for girls and women. A clear test tied to biology can look, to them, like a basic fairness check.
Many liberals, on the other hand, see gene testing as another step toward singling out and stigmatizing an already vulnerable group. They tend to focus on how rules like this can be used to question people’s identity in public and fuel online harassment. Some also worry that big organizations talk about “fairness” while ignoring deeper issues, like unequal funding, coaching, and access that separate rich and poor players long before any lab test comes into play. Those gaps mirror wider economic divides in American life.
Gauff’s warning about ‘animosity’ and elite power
Gauff’s strongest words were not about the science of the SRY gene but about how people in power use the debate. She said the conversation around the rule “has created a lot of animosity toward the trans community,” which she opposed. She called out people using the policy as a “reason to attack the trans community” even though they “don’t really care” about fairness or tennis. That concern speaks directly to a broader fear that culture fights are being stoked from above.
Coco Gauff Calls Out Trans Community Attacks, But 'Understands' WTA Gene Testing Policy Details: https://t.co/RHBIAPVtcd pic.twitter.com/QWA325vT5a
— Complex (@Complex) August 6, 2026
The rollout also raised trust issues that will sound familiar to many Americans. Some players only learned about the change when the press release went out. That kind of top-down move mirrors what many on both the right and left resent in Washington: big decisions made by officials, lawyers, and consultants, with ordinary people informed after the fact. Whether it is trade deals, energy rules, or now gene tests in sports, many feel the same small group of global and corporate elites keeps rewriting the rules of the game.
Why this debate matters beyond tennis
For a lot of fans, this is not just a story about tennis but about who gets to define “fairness” in modern America. Sports used to feel simple: men’s leagues, women’s leagues, and kids playing for fun and pride. Now, rules are tied to genetic markers, Olympic requirements, and executive orders from faraway capitals. That complexity feeds the sense that regular people have lost control while lawyers and scientists argue over what should be common-sense questions.
Gauff is trying to hold two ideas at once: real biological differences matter in competition, and real people in the trans community deserve safety and respect. Many Americans, left and right, quietly agree with both statements but feel forced by politics to pick a side. Her comments highlight a path that rejects both cruelty and denial. At the same time, the way this rule was built and rolled out shows why growing numbers believe powerful institutions, whether in sports or government, are serving their own interests first and the public’s second.
Sources:
facebook.com, nytimes.com, thepinknews.com, ground.news
